FDA Seeks Participants for Generic Drug Fee Renewal Talks
Published Date: 6/26/2025
Notice
Summary
The FDA is inviting patients, doctors, scientists, and others to join talks about renewing fees for generic drugs from 2028 to 2032. These fees help keep generic medicines affordable and available. If you want to join the conversation, let the FDA know soon so they can plan regular meetings and keep things moving smoothly.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in